Andra Ap Fonden Ionis Pharmaceuticals Inc Transaction History

Andra Ap Fonden

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$34.54 - $47.25 $2.06 Million - $2.82 Million	-59,700 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$42.51 - $63.78 $1.09 Million - $1.63 Million	-25,600 Reduced 30.01%	59,700 $2.68 Million
Q4 2020 Feb 12, 2021	BUY	$45.3 - $60.27 $1.13 Million - $1.51 Million	25,000 Added 41.46%	85,300 $4.82 Million
Q3 2020 Nov 12, 2020	SELL	$47.45 - $62.95 $887,315 - $1.18 Million	-18,700 Reduced 23.67%	60,300 $2.86 Million
Q2 2020 Aug 06, 2020	SELL	$46.85 - $61.05 $890,150 - $1.16 Million	-19,000 Reduced 19.39%	79,000 $4.66 Million
Q1 2020 May 13, 2020	BUY	$41.6 - $63.4 $1.6 Million - $2.43 Million	38,400 Added 64.43%	98,000 $4.63 Million
Q4 2019 Feb 10, 2020	BUY	$53.85 - $65.27 $1.23 Million - $1.49 Million	22,900 Added 62.4%	59,600 $3.6 Million
Q2 2019 Aug 15, 2019	BUY	$62.09 - $86.14 $2.28 Million - $3.16 Million	36,700 New	36,700 $2.36 Million

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

Stay updated on Andra Ap Fonden with notifications on news.